167 related articles for article (PubMed ID: 9870857)
1. Possible relation of osteopontin to development of psammoma bodies in human papillary thyroid cancer.
Tunio GM; Hirota S; Nomura S; Kitamura Y
Arch Pathol Lab Med; 1998 Dec; 122(12):1087-90. PubMed ID: 9870857
[TBL] [Abstract][Full Text] [Related]
2. Expression of bone-related protein messenger RNA in human meningiomas: possible involvement of osteopontin in development of psammoma bodies.
Hirota S; Nakajima Y; Yoshimine T; Kohri K; Nomura S; Taneda M; Hayakawa T; Kitamura Y
J Neuropathol Exp Neurol; 1995 Sep; 54(5):698-703. PubMed ID: 7666059
[TBL] [Abstract][Full Text] [Related]
3. Expression of osteopontin messenger RNA by macrophages in ovarian serous papillary cystadenocarcinoma: a possible association with calcification of psammoma bodies.
Maki M; Hirota S; Kaneko Y; Morohoshi T
Pathol Int; 2000 Jul; 50(7):531-5. PubMed ID: 10886734
[TBL] [Abstract][Full Text] [Related]
4. Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci.
Hirota S; Ito A; Nagoshi J; Takeda M; Kurata A; Takatsuka Y; Kohri K; Nomura S; Kitamura Y
Lab Invest; 1995 Jan; 72(1):64-9. PubMed ID: 7837792
[TBL] [Abstract][Full Text] [Related]
5. Localization of osteopontin at calcification sites of cholesteatoma: possible role as a regulator of deposition of calcium phosphate in the middle ear.
Makiishi-Shimobayashi C; Tsujimura T; Iwasaki T; Kakihana M; Shimano K; Terada N; Sakagami M
Auris Nasus Larynx; 2004 Mar; 31(1):3-9. PubMed ID: 15041047
[TBL] [Abstract][Full Text] [Related]
6. Localization of the mRNA for bone matrix proteins during fracture healing as determined by in situ hybridization.
Hirakawa K; Hirota S; Ikeda T; Yamaguchi A; Takemura T; Nagoshi J; Yoshiki S; Suda T; Kitamura Y; Nomura S
J Bone Miner Res; 1994 Oct; 9(10):1551-7. PubMed ID: 7817800
[TBL] [Abstract][Full Text] [Related]
7. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification.
Hirota S; Imakita M; Kohri K; Ito A; Morii E; Adachi S; Kim HM; Kitamura Y; Yutani C; Nomura S
Am J Pathol; 1993 Oct; 143(4):1003-8. PubMed ID: 8213995
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness.
Guarino V; Faviana P; Salvatore G; Castellone MD; Cirafici AM; De Falco V; Celetti A; Giannini R; Basolo F; Melillo RM; Santoro M
J Clin Endocrinol Metab; 2005 Sep; 90(9):5270-8. PubMed ID: 15998773
[TBL] [Abstract][Full Text] [Related]
9. Correlation between calcification and bone sialoprotein and osteopontin in papillary thyroid carcinoma.
Wu G; Guo JJ; Ma ZY; Wang J; Zhou ZW; Wang Y
Int J Clin Exp Pathol; 2015; 8(2):2010-7. PubMed ID: 25973097
[TBL] [Abstract][Full Text] [Related]
10. Role of osteopontin in the rodent inner ear as revealed by in situ hybridization.
Sakagami M
Med Electron Microsc; 2000; 33(1):3-10. PubMed ID: 11810451
[TBL] [Abstract][Full Text] [Related]
11. Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts.
Petrow PK; Hummel KM; Schedel J; Franz JK; Klein CL; Müller-Ladner U; Kriegsmann J; Chang PL; Prince CW; Gay RE; Gay S
Arthritis Rheum; 2000 Jul; 43(7):1597-605. PubMed ID: 10902765
[TBL] [Abstract][Full Text] [Related]
12. OPNa Overexpression Is Associated with Matrix Calcification in Thyroid Cancer Cell Lines.
Ferreira LB; Lima RT; Bastos ACSDF; Silva AM; Tavares C; Pestana A; Rios E; Eloy C; Sobrinho-Simões M; Gimba ERP; Soares P
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274371
[TBL] [Abstract][Full Text] [Related]
13. Impaired expression of noncollagenous bone matrix protein mRNAs during fracture healing in ascorbic acid-deficient rats.
Sugimoto M; Hirota S; Sato M; Kawahata H; Tsukamoto I; Yasui N; Kitamura Y; Ochi T; Nomura S
J Bone Miner Res; 1998 Feb; 13(2):271-8. PubMed ID: 9495521
[TBL] [Abstract][Full Text] [Related]
14. Autocrine stimulation by osteopontin plays a pivotal role in the expression of the mitogenic and invasive phenotype of RET/PTC-transformed thyroid cells.
Castellone MD; Celetti A; Guarino V; Cirafici AM; Basolo F; Giannini R; Medico E; Kruhoffer M; Orntoft TF; Curcio F; Fusco A; Melillo RM; Santoro M
Oncogene; 2004 Mar; 23(12):2188-96. PubMed ID: 14981541
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin (OPN) expression in thyroid carcinoma.
Briese J; Cheng S; Ezzat S; Liu W; Winer D; Wagener C; Bamberger AM; Asa SL
Anticancer Res; 2010 May; 30(5):1681-8. PubMed ID: 20592361
[TBL] [Abstract][Full Text] [Related]
16. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
Sharp JA; Sung V; Slavin J; Thompson EW; Henderson MA
Lab Invest; 1999 Jul; 79(7):869-77. PubMed ID: 10418827
[TBL] [Abstract][Full Text] [Related]
17. Expression of transforming growth factor-beta1 and transforming growth factor-beta Type-II receptor mRNA in papillary thyroid carcinoma.
Matoba H; Sugano S; Yamaguchi N; Miyachi Y
Horm Metab Res; 1998 Oct; 30(10):624-8. PubMed ID: 9851670
[TBL] [Abstract][Full Text] [Related]
18. Expression of bone matrix proteins mRNA during distraction osteogenesis.
Sato M; Yasui N; Nakase T; Kawahata H; Sugimoto M; Hirota S; Kitamura Y; Nomura S; Ochi T
J Bone Miner Res; 1998 Aug; 13(8):1221-31. PubMed ID: 9718189
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin expression and distribution in human carcinomas.
Brown LF; Papadopoulos-Sergiou A; Berse B; Manseau EJ; Tognazzi K; Perruzzi CA; Dvorak HF; Senger DR
Am J Pathol; 1994 Sep; 145(3):610-23. PubMed ID: 8080043
[TBL] [Abstract][Full Text] [Related]
20. Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.
Jin H; Valverde P; Chen J
Arch Oral Biol; 2006 Mar; 51(3):236-45. PubMed ID: 16095557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
